A Study of Artificial Intelligence ECG With ECG Devices to Detect Hypertrophic Cardiomyopathy Distinct From Athlete's Heart

Launched by MAYO CLINIC · Feb 26, 2024

Keywords

ClinConnect Summary

This clinical trial is testing a new technology that uses artificial intelligence (AI) to analyze heart rhythms and help identify a condition called hypertrophic cardiomyopathy (HCM). HCM is a heart condition where the heart muscle becomes too thick, which can lead to serious health issues. The study aims to see if the AI can not only detect HCM but also tell it apart from "athlete's heart," a condition that can occur in people who are very physically active. Researchers will use different devices, including a standard ECG machine and popular tools like the Apple Watch and KardiaMobile, to gather heart data.

To participate in this study, individuals should be aged between 65 and 74 and have a confirmed diagnosis of either HCM or athlete's heart, supported by imaging tests. The study is currently recruiting participants, and if you qualify, you can expect to contribute to important research that could improve how these heart conditions are diagnosed in the future. Your involvement would help doctors better understand how to use AI in heart health, and you’ll be contributing to advancements that could benefit many patients down the line.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with clinically validated diagnoses of HCM (n=150) and athlete's heart (n=150) will be identified by pre-screening of the clinic appointments for each of the specialty HCM and Sports Cardiology clinics or in the CV fellows' clinic (in patients with an established diagnosis and no pending testing). All diagnoses will need to be supported by unequivocal imaging and other ancillary data per our standard of care and at the determination of clinic experts.
• Exclusion Criteria:
• • Any exception to the above criteria.